Johnson Chemical Pharmaceutical Works Co Ltd (4747) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.012x

Based on the latest financial reports, Johnson Chemical Pharmaceutical Works Co Ltd (4747) has a cash flow conversion efficiency ratio of 0.012x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$21.25 Million ≈ $669.40K USD) by net assets (NT$1.71 Billion ≈ $53.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Johnson Chemical Pharmaceutical Works Co (4747) balance sheet quality index to measure how much of total assets are equity-financed.

Johnson Chemical Pharmaceutical Works Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Johnson Chemical Pharmaceutical Works Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Johnson Chemical Pharmaceutical Works Co (4747) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Johnson Chemical Pharmaceutical Works Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Johnson Chemical Pharmaceutical Works Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
CONCORD ENVIRO SYSTEMS L NSE:CEWATER	-0.074x
Korea Business News Co. Ltd KQ:039340	0.032x
Bibica Corp VN:BBC	0.032x
Marshall Monteagle PLC JSE:MMP	-0.042x
Dutaland Bhd KLSE:3948	-0.019x
International Media Acquisition Corp NASDAQ:IMAQ	0.023x
Sekar Laut Tbk JK:SKLT	-0.004x
Kilitch Drugs (India) Limited NSE:KILITCH	-0.025x

Annual Cash Flow Conversion Efficiency for Johnson Chemical Pharmaceutical Works Co Ltd (2009–2024)

The table below shows the annual cash flow conversion efficiency of Johnson Chemical Pharmaceutical Works Co Ltd from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see Johnson Chemical Pharmaceutical Works Co stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$1.70 Billion ≈ $53.68 Million	NT$62.88 Million ≈ $1.98 Million	0.037x	-54.95%
2023-12-31	NT$1.67 Billion ≈ $52.68 Million	NT$136.95 Million ≈ $4.31 Million	0.082x	-20.39%
2022-12-31	NT$871.66 Million ≈ $27.46 Million	NT$89.69 Million ≈ $2.83 Million	0.103x	+66.72%
2021-12-31	NT$848.24 Million ≈ $26.72 Million	NT$52.35 Million ≈ $1.65 Million	0.062x	-26.21%
2020-12-31	NT$858.20 Million ≈ $27.04 Million	NT$71.77 Million ≈ $2.26 Million	0.084x	-0.84%
2019-12-31	NT$847.97 Million ≈ $26.72 Million	NT$71.52 Million ≈ $2.25 Million	0.084x	+3.52%
2018-12-31	NT$836.53 Million ≈ $26.36 Million	NT$68.15 Million ≈ $2.15 Million	0.081x	+70.61%
2017-12-31	NT$835.43 Million ≈ $26.32 Million	NT$39.89 Million ≈ $1.26 Million	0.048x	-41.76%
2016-12-31	NT$832.41 Million ≈ $26.23 Million	NT$68.25 Million ≈ $2.15 Million	0.082x	+60.49%
2015-12-31	NT$821.60 Million ≈ $25.88 Million	NT$41.97 Million ≈ $1.32 Million	0.051x	-60.87%
2014-12-31	NT$635.01 Million ≈ $20.01 Million	NT$82.91 Million ≈ $2.61 Million	0.131x	-3.19%
2013-12-31	NT$583.53 Million ≈ $18.38 Million	NT$78.70 Million ≈ $2.48 Million	0.135x	+80.40%
2012-12-31	NT$386.30 Million ≈ $12.17 Million	NT$28.88 Million ≈ $909.94K	0.075x	-47.75%
2011-12-31	NT$353.39 Million ≈ $11.13 Million	NT$50.57 Million ≈ $1.59 Million	0.143x	+66.91%
2010-12-31	NT$324.45 Million ≈ $10.22 Million	NT$27.81 Million ≈ $876.26K	0.086x	-7.16%
2009-12-31	NT$311.47 Million ≈ $9.81 Million	NT$28.76 Million ≈ $906.10K	0.092x	--

About Johnson Chemical Pharmaceutical Works Co Ltd

TWO:4747 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$69.08 Million

NT$2.19 Billion TWD

Market Cap Rank

#20633 Global

#1239 in Taiwan

Share Price

NT$48.80

Change (1 day)

-1.21%

52-Week Range

NT$48.00 - NT$77.00

All Time High

NT$115.60